Clinical Characteristics and Growth Hormone Treatment in Patients with Prader-Willi Syndrome

• Egile Nagusiak: Aydilek Dağdeviren Çakır (Egilea), Firdevs Baş (Egilea), Onur Akın (Egilea), Zeynep Şıklar (Egilea), Bahar Özcabı (Egilea), Merih Berberoğlu (Egilea), Aslı Derya Kardelen (Egilea), Elvan Bayramoğlu (Egilea), Şükran Poyrazoğlu (Egilea), Murat Aydın (Egilea), Ayça Törel Ergür (Egilea), Damla Gökşen (Egilea), Semih Bolu (Egilea), Zehra Aycan (Egilea), Beyhan Tüysüz (Egilea), Oya Ercan (Egilea), Olcay Evliyaoğlu (Egilea)
• Formatua: Liburua
• Argitaratua: Galenos Yayincilik, 2021-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objective:To investigate clinical characteristics and response to growth hormone (GH) treatment in patients with Prader-Willi syndrome (PWS) in Turkey.Methods:The data of 52 PWS patients from ten centers was retrospectively analyzed. A nation-wide, web-based data system was used for data collection....